Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-25-020109

EVP Research & Development sold 2,000 shares at $36.34 ($72,680)

  • EVP Research & Development acquired 2,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Malik Fady Ibraham · EVP Research & Development

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-05 Exercise or conversion : show line 1 in the form 10b5-1 +2,000 $10.60 $21,200 142,610 D
2025-08-05 Sale : show line 2 in the form 10b5-1 −2,000 $36.34 $72,680 140,610 D
Open-market sales · 2,000 sh · avg $36.34 · $72,680

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-05 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) −2,000 11,105 D
Loading xslF345X05/form4.xml…